We are live on ! Find out more
S

SignatureFD Portfolio holdings

AUM $7.49B
1-Year Est. Return 24.82%
This Fund
S&P 500
This Quarter Est. Return
+7.92%
1 Year Est. Return
+24.82%
3 Year Est. Return
+73.56%
5 Year Est. Return
+79.97%
10 Year Est. Return
+256.52%
AUM
$3.25B
AUM Growth
+$358M
Cap. Flow
+$138M
Cap. Flow %
4.23%
Top 10 Hldgs %
63.35%
Holding
3,391
New
290
Increased
1,484
Reduced
798
Closed
229

Sector Composition

Rank Sector Weight
1 Technology 8.07%
2 Consumer Discretionary 4.3%
3 Financials 3.96%
4 Healthcare 3.29%
5 Consumer Staples 2.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HARP
3326
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
-15
Closed -$1K
ACGN
3327
DELISTED
Aceragen Inc
ACGN
$0 ﹤0.01%
11
APPH
3328
DELISTED
AppHarvest, Inc. Common Stock
APPH
$0 ﹤0.01%
30
VRAY
3329
DELISTED
ViewRay, Inc.
VRAY
-216
Closed -$2K
EVLO
3330
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$0 ﹤0.01%
+4
New +$675
BBLN
3331
DELISTED
Babylon Holdings Limited
BBLN
-40
Closed -$10K
HEXO
3332
DELISTED
HEXO Corp. Common Shares
HEXO
$0 ﹤0.01%
5
TCRR
3333
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-103
Closed -$1K
MNTV
3334
DELISTED
Momentive Global Inc. Common Stock
MNTV
$0 ﹤0.01%
+22
New +$484
PLXP
3335
DELISTED
PLx Pharma Inc. Common Stock
PLXP
-600
Closed -$12K
MYOV
3336
DELISTED
Myovant Sciences Ltd.
MYOV
-35
Closed -$1K
LHDX
3337
DELISTED
Lucira Health, Inc. Common Stock
LHDX
-215
Closed -$2K
ALBO
3338
DELISTED
Albireo Pharma Inc
ALBO
-33
Closed -$1K
SRNE
3339
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-191
Closed -$1K
ATNX
3340
DELISTED
Athenex, Inc. Common Stock
ATNX
-36
Closed -$2K
BIOT
3341
DELISTED
Biotech Acquisition Company Class A Ordinary Shares
BIOT
-72
Closed -$1K
ASAP
3342
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
$0 ﹤0.01%
2
BSJM
3343
DELISTED
Invesco BulletShares 2022 High Yield Corporate Bond ETF
BSJM
-1,302
Closed -$30K
AKUS
3344
DELISTED
Akouos Inc
AKUS
-78
Closed -$1K
AERI
3345
DELISTED
Aerie Pharmaceuticals
AERI
-67
Closed -$1K
QTNT
3346
DELISTED
Quotient Limited Ordinary Shares
QTNT
-7
Closed -$1K
ZEAL
3347
DELISTED
Zealand Pharma A/S American Depositary Shares
ZEAL
-167
Closed -$5K
ATHX
3348
DELISTED
Athersys, Inc. Common Stock
ATHX
$0 ﹤0.01%
5
-54
-92% -$1.55K
RDUS
3349
DELISTED
Radius Health, Inc.
RDUS
-64
Closed -$1K
ANAT
3350
DELISTED
American National Group, Inc. Common Stock
ANAT
-26
Closed -$5K

Similar funds

SignatureFD's Q4 2021 Portfolio in Review

As of Q4 2021, SignatureFD held 3,391 positions worth $3.25B, up 12% from $2.89B the previous quarter. Its ten largest holdings account for 63% of the portfolio.

SignatureFD deployed $138M of net new capital in Q4 2021, opening 290 new positions and adding to 1,484 existing holdings. Its largest new stake was Invesco DB US Dollar Index Bearish Fund: 40,000 shares worth $810K.

By sector, the portfolio is most concentrated in Technology at 8.1% of assets, up from 7.8% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was JPMorgan Ultra-Short Income ETF, an estimated $9.57M trimmed.

  • SignatureFD's largest Q4 2021 buy was Invesco DB US Dollar Index Bearish Fund: 40,000 shares worth $810K.
  • SignatureFD added most to iShares Core MSCI EAFE ETF in Q4 2021, an estimated $24.3M increase.
  • SignatureFD's biggest Q4 2021 reduction was JPMorgan Ultra-Short Income ETF, cutting an estimated $9.57M.
  • SignatureFD fully exited iShares ESG Aware US Aggregate Bond ETF in Q4 2021, selling an estimated $877K.
  • SignatureFD's ten largest holdings make up 63% of its $3.25B portfolio in Q4 2021.
  • SignatureFD opened 290 new positions and closed 229 in Q4 2021.
  • SignatureFD's portfolio value rose 12% quarter-over-quarter to $3.25B.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.